Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For PSNY
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio -6.81 0.55 0.59
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -62.42 -9.71 -5.98
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value -33.59 -0.30 -0.22
Cash -10.06 0.45 0.50
Capex 58.72 -0.03 -0.07
Free Cash Flow -39.54 -0.35 -0.25
Revenue -10.53 0.29 0.32
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin 396.82 < 0.005 < 0.005
Operating Margin -6.40 -0.43 -0.40
ROA 50.43 -0.04 -0.07
ROE -61.75 0.25 0.65
ROIC 12.29 -0.11 -0.13
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of PSNY is permitted for members.
5 Growth
The "Growth Entry" for the Focus of PSNY is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of PSNY is permitted for members.